{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T10:31:29Z","timestamp":1780482689534,"version":"3.54.1"},"reference-count":46,"publisher":"Oxford University Press (OUP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1093\/toxsci\/kfx135","type":"journal-article","created":{"date-parts":[[2017,6,27]],"date-time":"2017-06-27T19:11:20Z","timestamp":1498590680000},"page":"279-289","source":"Crossref","is-referenced-by-count":10,"title":["Permitted Daily Exposure of the Androgen Receptor Antagonist Flutamide"],"prefix":"10.1093","volume":"159","author":[{"given":"Lefteris C.","family":"Zacharia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,6,28]]},"reference":[{"key":"key\n\t\t\t\t20170925085541_kfx135-B1","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.reprotox.2007.08.001","article-title":"In vivo and invitro effects of flutamide and diethylstilbestrol on fetal testicular steroidogenesis in the rat","volume":"25","year":"2008","journal-title":"Reprod. Toxicol."},{"key":"key\n\t\t\t\t20170925085541_kfx135-B2","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1046\/j.1464-410X.2003.04026.x","article-title":"The role of antiandrogen monotherapy in the treatment of prostate cancer","volume":"91","year":"2003","journal-title":"BJU Int."},{"key":"key\n\t\t\t\t20170925085541_kfx135-B3","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s002040100214","article-title":"Feasibility and potential gains of enhancing the subacute rat study protocol (OECD test guideline no. 407) by additional parameters selected to determine endocrine modulation. A pre-validation study to determine endocrine-mediated effects of the antiandrogenic drug flutamide","volume":"75","year":"2001","journal-title":"Arch. Toxicol."},{"key":"key\n\t\t\t\t20170925085541_kfx135-B4","article-title":"Review of non-monotonic dose-responses of substances for human risk assessment","year":"2016"},{"key":"key\n\t\t\t\t20170925085541_kfx135-B5","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.yrtph.2011.10.012","article-title":"The human relevant potency threshold: Reducing uncertainty by human calibration of cumulative risk assessments","volume":"62","year":"2012","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"key\n\t\t\t\t20170925085541_kfx135-B6","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/bdrb.21096","article-title":"Relevance weighting of tier 1 endocrine screening endpoints by rank order","volume":"101","year":"2014","journal-title":"Birth Defects Res. B Dev. Reprod. Toxicol."},{"key":"key\n\t\t\t\t20170925085541_kfx135-B7","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1677\/joe.1.05771","article-title":"The mitochondrial-dependent pathway is chronically affected in testicular germ cell death in adult rats exposed in utero to anti-androgens","volume":"183","year":"2004","journal-title":"J. Endocrinol."},{"key":"key\n\t\t\t\t20170925085541_kfx135-B8","year":"2014"},{"key":"key\n\t\t\t\t20170925085541_kfx135-B9","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1080\/10408449991349203","article-title":"Rodent Leydig cell tumorigenesis: A review of the physiology, pathology, mechanisms, and relevance to humans","volume":"29","year":"1999","journal-title":"Crit. Rev. Toxicol."},{"key":"key\n\t\t\t\t20170925085541_kfx135-B10","volume-title":"EMA\/CVMP\/VICH\/502\/1999-Rev.1","author":"CVPM","year":"2010"},{"key":"key\n\t\t\t\t20170925085541_kfx135-B11","volume-title":"EMA\/CHMP\/ CVMP\/ SWP\/169430\/2012","author":"EMEA","year":"2014"},{"key":"key\n\t\t\t\t20170925085541_kfx135-B12","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1351\/pac200375112483","article-title":"Testing of endocrine active substances using an enhanced OECD test guideline 407: Experiences from studies on flutamide and ethinylestradiol","volume":"75","year":"2003","journal-title":"Pure Appl. Chem."},{"key":"key\n\t\t\t\t20170925085541_kfx135-B13","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1093\/toxsci\/kfm022","article-title":"Correlation between protein accumulation profiles and conventional toxicological findings using a model antiandrogenic compound, flutamide","volume":"97","year":"2007","journal-title":"Toxicol. Sci."},{"key":"key\n\t\t\t\t20170925085541_kfx135-B14","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1007\/s00204-015-1622-6","article-title":"Investigations of putative reproductive toxicity of low-dose exposures to flutamide in Wistar rats","volume":"89","year":"2015","journal-title":"Arch. Toxicol."},{"key":"key\n\t\t\t\t20170925085541_kfx135-B15","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0890-6238(99)00036-2","article-title":"Interpreting the toxicologic significance of alterations in anogenital distance: Potential for confounding effects of progeny body weights","volume":"13","year":"1999","journal-title":"Reprod. Toxicol."},{"key":"key\n\t\t\t\t20170925085541_kfx135-B16","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.yfrne.2008.02.002","article-title":"Developmental programming and endocrine disruptor effects on reproductive neuroendocrine systems","volume":"29","year":"2008","journal-title":"Front. Neuroendocrinol."},{"key":"key\n\t\t\t\t20170925085541_kfx135-B17","first-page":"122","article-title":"Combined exposure to anti-androgens exacerbates disruption of sexual differentiation in the rat","volume":"115(Suppl 1)","year":"2007","journal-title":"Environ. Health Perspect."},{"key":"key\n\t\t\t\t20170925085541_kfx135-B18","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.tox.2004.02.019","article-title":"Comparison of anti-androgenic activity of flutamide, vinclozolin, procymidone, linuron, and p, p'-DDE in rodent 10-day Hershberger assay","volume":"199","year":"2004","journal-title":"Toxicology"},{"key":"key\n\t\t\t\t20170925085541_kfx135-B19","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1093\/toxsci\/67.1.52","article-title":"Evaluation of the 20-day pubertal female assay in Sprague-Dawley rats treated with DES, tamoxifen, testosterone, and flutamide","volume":"67","year":"2002","journal-title":"Toxicol. Sci."},{"key":"key\n\t\t\t\t20170925085541_kfx135-B20","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.beem.2008.01.004","article-title":"Maximal androgen blockade for advanced prostate cancer","volume":"22","year":"2008","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"key\n\t\t\t\t20170925085541_kfx135-B21","first-page":"98","article-title":"Ten years of mixing cocktails: A review of combination effects of endocrine-disrupting chemicals","volume":"115(Suppl 1)","year":"2007","journal-title":"Environ. Health Perspect."},{"key":"key\n\t\t\t\t20170925085541_kfx135-B22","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.tox.2004.03.007","article-title":"Evaluation for reliability and feasibility of the draft protocol for the enhanced rat 28-day subacute study (OECD Guideline 407) using androgen antagonist flutamide","volume":"200","year":"2004","journal-title":"Toxicology"},{"key":"key\n\t\t\t\t20170925085541_kfx135-B23","doi-asserted-by":"crossref","first-page":"13.","DOI":"10.1186\/1476-069X-14-13","article-title":"Non-monotonic dose-response relationships and endocrine disruptors: A qualitative method of assessment","volume":"14","year":"2015","journal-title":"Environ. Health"},{"key":"key\n\t\t\t\t20170925085541_kfx135-B24","first-page":"541","article-title":"Female pattern alopecia: Current perspectives","volume":"5","year":"2013","journal-title":"Int. J. Womens Health"},{"key":"key\n\t\t\t\t20170925085541_kfx135-B25","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1093\/toxsci\/kfr099","article-title":"A molecular and phenotypic integrative approach to identify a no-effect dose level for antiandrogen-induced testicular toxicity","volume":"122","year":"2011","journal-title":"Toxicol. Sci."},{"key":"key\n\t\t\t\t20170925085541_kfx135-B26","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.tem.2009.03.009","article-title":"Endocrine disruptors in female reproductive tract development and carcinogenesis","volume":"20","year":"2009","journal-title":"Trends Endocrinol. Metab."},{"key":"key\n\t\t\t\t20170925085541_kfx135-B27","doi-asserted-by":"crossref","first-page":"5135","DOI":"10.1210\/en.2005-0592","article-title":"Alteration of transforming growth factor-beta signaling system expression in adult rat germ cells with a chronic apoptotic cell death process after fetal androgen disruption","volume":"146","year":"2005","journal-title":"Endocrinology"},{"key":"key\n\t\t\t\t20170925085541_kfx135-B28","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1034\/j.1600-0773.2000.d01-24.x","article-title":"Evaluation of flutamide genotoxicity in rats and in primary human hepatocytes","volume":"86","year":"2000","journal-title":"Pharmacol. Toxicol."},{"key":"key\n\t\t\t\t20170925085541_kfx135-B29","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1093\/toxsci\/62.2.236","article-title":"Androgen-mediated development in male rat offspring exposed to flutamide in utero: Permanence and correlation of early postnatal changes in anogenital distance and nipple retention with malformations in androgen-dependent tissues","volume":"62","year":"2001","journal-title":"Toxicol. Sci."},{"key":"key\n\t\t\t\t20170925085541_kfx135-B30","author":"Merck","year":"2011"},{"key":"key\n\t\t\t\t20170925085541_kfx135-B31","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/toxsci\/kfm079","article-title":"Dysgenesis and histological changes of genitals and perturbations of gene expression in male rats after in utero exposure to antiandrogen mixtures","volume":"98","year":"2007","journal-title":"Toxicol. Sci."},{"key":"key\n\t\t\t\t20170925085541_kfx135-B32","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2131\/jts.27.19","article-title":"Effects of perinatal exposure to flutamide on sex hormones and androgen-dependent organs in F1 male rats","volume":"27","year":"2002","journal-title":"J. Toxicol. Sci."},{"key":"key\n\t\t\t\t20170925085541_kfx135-B33","doi-asserted-by":"crossref","DOI":"10.1787\/9789264070684-en","volume-title":"Test No. 407: Repeated Dose 28-day Oral Toxicity Study in Rodents","author":"OECD","year":"2008"},{"key":"key\n\t\t\t\t20170925085541_kfx135-B34","doi-asserted-by":"crossref","DOI":"10.1787\/9789264076334-en","volume-title":"Test No. 441: Hershberger Bioassay in Rats.","author":"OECD","year":"2009"},{"key":"key\n\t\t\t\t20170925085541_kfx135-B35","first-page":"63","article-title":"Collaborative work to evaluate toxicity on male reproductive organs by repeated dose studies in rats 5). Effects of repeated doses of flutamide for 2 and 4\u2009weeks","volume":"25 (Spec No)","year":"2000","journal-title":"J. Toxicol. Sci."},{"key":"key\n\t\t\t\t20170925085541_kfx135-B36","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1439-0272.2004.00641.x","article-title":"The male reproductive system and its susceptibility to endocrine disrupting chemicals","volume":"36","year":"2004","journal-title":"Andrologia"},{"key":"key\n\t\t\t\t20170925085541_kfx135-B38","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1517\/14740338.2014.966686","article-title":"Safety of antiandrogen therapy for treating prostate cancer","volume":"13","year":"2014","journal-title":"Expert Opin. Drug Saf."},{"key":"key\n\t\t\t\t20170925085541_kfx135-B39","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1093\/toxsci\/kfp056","article-title":"Standard and molecular NOAELs for rat testicular toxicity induced by flutamide","volume":"109","year":"2009","journal-title":"Toxicol. Sci."},{"key":"key\n\t\t\t\t20170925085541_kfx135-B40","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.taap.2015.10.009","article-title":"Low dose evaluation of the antiandrogen flutamide following a Mode of Action approach","volume":"289","year":"2015","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"key\n\t\t\t\t20170925085541_kfx135-B41","year":"2008"},{"key":"key\n\t\t\t\t20170925085541_kfx135-B42","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s40257-014-0078-4","article-title":"Hirsutism: An evidence-based treatment update","volume":"15","year":"2014","journal-title":"Am. J. Clin. Dermatol."},{"key":"key\n\t\t\t\t20170925085541_kfx135-B43","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s002040050664","article-title":"Repeated dose (28 days) oral toxicity study of flutamide in rats, based on the draft protocol for the \u2018Enhanced OECD Test Guideline 407\u2019 for screening for endocrine-disrupting chemicals","volume":"74","year":"2000","journal-title":"Arch. Toxicol."},{"key":"key\n\t\t\t\t20170925085541_kfx135-B47","author":"USP"},{"key":"key\n\t\t\t\t20170925085541_kfx135-B44","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1210\/er.2011-1050","article-title":"Hormones and endocrine-disrupting chemicals: Low-dose effects and nonmonotonic dose responses","volume":"33","year":"2012","journal-title":"Endocr. Rev."},{"key":"key\n\t\t\t\t20170925085541_kfx135-B45","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1093\/toxsci\/53.2.289","article-title":"Comparative evaluation of a 5-day Hershberger assay utilizing mature male rats and a pubertal male assay for detection of flutamide\u2019s antiandrogenic activity","volume":"53","year":"2000","journal-title":"Toxicol. Sci."},{"key":"key\n\t\t\t\t20170925085541_kfx135-B46","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.tox.2004.12.004","article-title":"Effects of in utero and lactational exposure to flutamide in SD rats: Comparison of the effects of administration periods","volume":"209","year":"2005","journal-title":"Toxicology"}],"container-title":["Toxicological Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/toxsci\/article-pdf\/159\/2\/279\/20094386\/kfx135.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,27]],"date-time":"2019-09-27T07:09:16Z","timestamp":1569568156000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/toxsci\/article\/159\/2\/279\/3896878\/Permitted-Daily-Exposure-of-the-Androgen-Receptor"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,28]]},"references-count":46,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2017,6,28]]},"published-print":{"date-parts":[[2017,10]]}},"URL":"https:\/\/doi.org\/10.1093\/toxsci\/kfx135","relation":{},"ISSN":["1096-6080","1096-0929"],"issn-type":[{"value":"1096-6080","type":"print"},{"value":"1096-0929","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,28]]}}}